CN103508898B - A kind of preparation method of new alverine citrate - Google Patents

A kind of preparation method of new alverine citrate Download PDF

Info

Publication number
CN103508898B
CN103508898B CN201210233874.2A CN201210233874A CN103508898B CN 103508898 B CN103508898 B CN 103508898B CN 201210233874 A CN201210233874 A CN 201210233874A CN 103508898 B CN103508898 B CN 103508898B
Authority
CN
China
Prior art keywords
preparation
alverine citrate
phenyl
alverine
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201210233874.2A
Other languages
Chinese (zh)
Other versions
CN103508898A (en
Inventor
赵凯
侯建平
赵亚峰
苑洪忠
赵孝先
简勇学
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HEBEI KAISHENG MEDICAL TECHNOLOGY Co Ltd
Original Assignee
HEBEI KAISHENG MEDICAL TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HEBEI KAISHENG MEDICAL TECHNOLOGY Co Ltd filed Critical HEBEI KAISHENG MEDICAL TECHNOLOGY Co Ltd
Priority to CN201210233874.2A priority Critical patent/CN103508898B/en
Publication of CN103508898A publication Critical patent/CN103508898A/en
Application granted granted Critical
Publication of CN103508898B publication Critical patent/CN103508898B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a kind of preparation method of new alverine citrate, with 3-phenyl halogenopropane and ethylamine hydrochloride for starting raw material, in alkaline system, reaction generates diphenylpropyl ethamine, organic layer and Citric Acid effect, obtains alverine citrate through refining.This operational path has raw material and is easy to get, and reactions steps is few, mild condition, simple to operate, yield high, is an environmental friendliness and easy industrialized synthetic route.

Description

A kind of preparation method of new alverine citrate
Technical field
The present invention relates to a kind of preparation method of alverine citrate, belong to pharmaceutical synthesis field.Alverine citrate is the spasmolytic commonly used clinically.
Technical background
Alverine citrate (Alverine, molecular formula: C 20h 27nC 6h 8o 7, molecular weight: 473.6) is the Papaverine derivative of synthetic, within 1996, in western countries' listing, it directly acts on unstriated muscle, optionally acts on the unstriated muscle of gi tract, uterus and Genito-urinary organ, have spasmolysis, structural formula is as follows:
The synthesis technique reported is that raw material obtains product through Grignard reaction, halogenation, amination and salify four step with benzyl chloride.
Mao Xiantong etc. report the pollution problem for existing in above-mentioned operational path, change technological line, get rid of the Grignard reaction making catalyzer with aluminum chloride, the new technology route that to change into methyl phenyl ketone and ethylamine hydrochloride be raw material, alverine citrate (Mao Xiantong etc., the study on the synthesis of spasmolytic alverine citrate intermediate is obtained through Mannich reaction, huang-Minlon reaction and Citric Acid salify three-step reaction.Hubei Chemical, 2000,4:23-24).This operational path method used is classical reaction, but reaction conditions is difficult to reach and larger to the harm of environment when scale operation, reaction needed as reducing carbonyl in huang-Minlon reaction is carried out under the condition of high temperature, and hydrazine reagent used has certain harm and toxicity to environment and people.
Chinese patent CN101838205A discloses the preparation method of a new alverine citrate.The method take phenylpropyl alcohol as starting raw material, phenylpropyl alcohol is obtained 3-phenyl-bromide propane through bromo-reaction, obtained N-ethylamphetamine is reacted again with ethylamine solution, N-ethylamphetamine more in the basic conditions with 3-phenyl bromopropane reaction, and obtain diphenylpropyl ethamine through molecular distillation, and last and Citric Acid effect obtains final product--alverine citrate.The method step is long, needs first to prepare N-ethylamphetamine, then prepares diphenylpropyl ethamine; Need the ethylamine solution using larger danger in addition, this solution boiling point is low, and bp is 16.6 DEG C, uses and stores equal inconvenience; Also will carry out molecular distillation operation, industrial being also difficult to realizes simultaneously.
Summary of the invention
The object of the present invention is to provide a kind of preparation method of new alverine citrate.
In order to overcome patent CN101838205A Problems existing, find through experimental study: with 3-phenyl halogenopropane and ethylamine hydrochloride for starting raw material, in alkaline system, carry out " one pot reaction " generate diphenylpropyl ethamine, organic layer after simple process directly and Citric Acid effect obtain alverine citrate.Instant invention overcomes the deficiency that patent CN101838205A substep prepares diphenylpropyl ethamine, a step has obtained this intermediate; Avoid the molecular distillation operation in former patent simultaneously, simplify technological process; In addition, the ethylamine solution that the present invention uses ethylamine hydrochloride to replace in former patent, reduces the danger in operating process.Therefore compare with conventional art, reaction conditions of the present invention is gentle, and simple to operate, safety, yield is high.
Realize object of the present invention by the following technical solutions: with 3-phenyl-chloride propane (3-phenyl halogenopropane) cheap and easy to get for starting raw material, 3-phenyl halogenopropane and ethylamine hydrochloride are carried out " one pot reaction " in alkaline system and generates diphenylpropyl ethamine, organic layer after simple process without molecular distillation directly and Citric Acid effect obtain alverine citrate, its chemical reaction process is as follows:
Compared with prior art, reaction conditions of the present invention is gentle, and operating process is easy, safety, is the operational path of a both economical practicality
Embodiment
Contribute to understanding the present invention by following example, but content of the present invention is not limited to example.
Embodiment 1: the preparation of alverine citrate
The first step: the preparation of diphenylpropyl ethamine
3-phenyl-bromide propane 20g (0.10mol) is added, ethylamine hydrochloride 4.1g (0.05mol), Tetrabutyl amonium bromide 0.2g and sodium hydroxide solution (35%-40%) 50ml in 250ml flask.Stirring is warming up to 85-90 DEG C, insulation reaction, and TLC follows the tracks of (ethyl acetate/petroleum ether=2: 1).After reaction terminates, extract water layer three times by ethyl acetate, merge organic layer.Add anhydrous sodium sulfate drying.Filter, filtrate reduced in volume obtains brown color liquid 13.5g.Yield: 96%.
Second step: the preparation of alverine citrate
Be dissolved in by aforesaid liquid 13.5g in 100ml dehydrated alcohol, join 9.2g (0.048mol) Citric Acid and be dissolved in the solution of 100ml dehydrated alcohol after stirring and dissolving, stirring at room temperature separates out solid.Filtration, washing, drying.Alverine citrate 15.2g is obtained with dehydrated alcohol recrystallization.Yield: 66.9%. 1HNMR(DMSO)δ:1.11~1.13(m,3H,-CH 2- CH 3 );1.88(s,4H,2- CH 2 -COOH);2.51~2.66(m,8H,2-CH 2- CH 2 -CH 2-,2-Φ- CH 2 -CH 2);2.98~3.06(m,6H,2-N- CH 2 -CH 2-,-N- CH 2 -CH 3);7.20~7.30(m,10H,Ph-H)。 13CNMR(DMSO)δ:8.79,24.98,31.99,44.25,46.95,50.79,71.68,126.05,128.26,128.37,140.70,171.63,176.96。
Embodiment 2: the preparation of alverine citrate
The first step: the preparation of diphenylpropyl ethamine
3-phenyl-chloride propane 15.5g (0.10mol) is added, ethylamine hydrochloride 4.1g (0.05mol), Tetrabutyl amonium bromide 0.2g and sodium hydroxide solution (35%-40%) 50ml in 250ml flask.Stirring is warming up to 85-90 DEG C, insulation reaction, and TLC follows the tracks of.After reaction terminates, extract water layer three times by ethyl acetate, merge organic layer.Add anhydrous sodium sulfate drying.Filter, filtrate reduced in volume obtains brown color liquid 12.4g.Yield: 88%.
Second step: the preparation of alverine citrate
Be dissolved in by aforesaid liquid 12.4g in 90ml dehydrated alcohol, join 8.5g (0.044mol) Citric Acid and be dissolved in the solution of 90ml dehydrated alcohol after stirring and dissolving, stirring at room temperature separates out solid.Filtration, washing, drying.Alverine citrate 13.5g is obtained with dehydrated alcohol recrystallization.Yield: 65.9%.
Embodiment 3: the preparation of alverine citrate
The first step: the preparation of diphenylpropyl ethamine
3-phenyl-bromide propane 20g (0.10mol), ethylamine hydrochloride 4.1g (0.05mol) and sodium hydroxide solution (35%-40%) 50ml is added in 250ml flask.Stirring is warming up to 85-90 DEG C, insulation reaction, and TLC follows the tracks of.After reaction terminates, extract water layer three times by ethyl acetate, merge organic layer.Add anhydrous sodium sulfate drying.Filter, filtrate reduced in volume obtains brown color liquid 10.8g.Yield: 76%.
Second step: the preparation of alverine citrate
Be dissolved in by aforesaid liquid 10.8g in 80ml dehydrated alcohol, join 7.4g (0.039mol) Citric Acid and be dissolved in the solution of 80ml dehydrated alcohol after stirring and dissolving, stirring at room temperature separates out solid.Filtration, washing, drying.Alverine citrate 11.2g is obtained with dehydrated alcohol recrystallization.Yield: 63.2%.
Embodiment 4: the preparation of alverine citrate
The first step: the preparation of diphenylpropyl ethamine
3-phenyl-chloride propane 15.5g (0.01mol) is added in 100ml flask, ethylamine hydrochloride 4.1g (0.05mol) and dehydrated alcohol 60ml, then add Anhydrous potassium carbonate 10.4g (0.075mol), stir and be warming up to backflow, insulation reaction.TLC follows the tracks of.After reaction terminates, filter, filtrate is not treated is directly used in next step reaction.
Second step: the preparation of alverine citrate
Join in 80ml dehydrated alcohol by 9.6g (0.05mol) Citric Acid, stirring and dissolving, then add the first step gained filtrate, stirring at room temperature is reacted, and separates out white solid, filtration, washing, drying.Alverine citrate 10.0g is obtained with dehydrated alcohol recrystallization.Yield: 42%.
Embodiment 5: the preparation of alverine citrate
The first step: the preparation of diphenylpropyl ethamine
3-phenyl-bromide propane 20g (0.10mol) is added, ethylamine hydrochloride 4.1g (0.05mol) and dehydrated alcohol 60ml in 100ml flask.Then add Anhydrous potassium carbonate 10.4g (0.075mol), stir and be warming up to backflow, insulation reaction, TLC follows the tracks of.After reaction terminates, filter, filtrate is not treated is directly used in next step reaction.
Second step: the preparation of alverine citrate
Join in 80ml dehydrated alcohol by 9.6g (0.05mol) Citric Acid, stirring and dissolving, then add the first step gained filtrate, stirring at room temperature is reacted, and separates out white solid, filtration, washing, drying.Alverine citrate 11.6g is obtained with dehydrated alcohol recrystallization.Yield: 48%.

Claims (3)

1. the preparation method of a new alverine citrate, it is characterized in that step (1) with 3-phenyl halogenopropane and ethylamine hydrochloride for starting raw material, in alkaline system, reaction generates diphenylpropyl ethamine, and wherein 3-phenyl halogenopropane is selected from is 3-phenyl-chloride propane, 3-phenyl-bromide propane; Step (2) and Citric Acid react obtained alverine citrate, and wherein in alkaline system, alkali is selected from NaOH or K 2cO 3.
2. the preparation method of alverine citrate according to claim 1, it is characterized in that alkaline system is by alkali and solvent composition, wherein solvent is selected from a kind of or its any two kinds and the above mixture in water, methyl alcohol, ethanol, acetone, THF, acetonitrile, DMF solvent.
3. the preparation method of the alverine citrate according to any one of claim 1-2, is characterized in that optionally using Tetrabutyl amonium bromide as catalyzer in step (1).
CN201210233874.2A 2012-06-26 2012-06-26 A kind of preparation method of new alverine citrate Active CN103508898B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210233874.2A CN103508898B (en) 2012-06-26 2012-06-26 A kind of preparation method of new alverine citrate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210233874.2A CN103508898B (en) 2012-06-26 2012-06-26 A kind of preparation method of new alverine citrate

Publications (2)

Publication Number Publication Date
CN103508898A CN103508898A (en) 2014-01-15
CN103508898B true CN103508898B (en) 2016-03-23

Family

ID=49892385

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210233874.2A Active CN103508898B (en) 2012-06-26 2012-06-26 A kind of preparation method of new alverine citrate

Country Status (1)

Country Link
CN (1) CN103508898B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105348110B (en) * 2015-12-18 2018-10-02 杨凌科森生物制药有限责任公司 A kind of alverine citrate crystal-form compound and combinations thereof
CN105461569B (en) * 2015-12-31 2017-06-06 南京海融医药科技股份有限公司 A kind of alverine citrate novel crystal forms and preparation method thereof
CN108658786B (en) * 2018-05-28 2019-12-03 吉林大学 A kind of remaining method of N- ethyl -3- phenylpropylamine in reduction alverine

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN85101106A (en) * 1983-10-22 1987-01-17 赫彻斯特股份公司 The preparation method of tertiary amine
US20040143009A1 (en) * 2002-11-05 2004-07-22 L'oreal Amines, uses thereof
CN101838205A (en) * 2009-03-16 2010-09-22 重庆北碚现代应用药物研究所 New method for preparing alverine citrate

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN85101106A (en) * 1983-10-22 1987-01-17 赫彻斯特股份公司 The preparation method of tertiary amine
US20040143009A1 (en) * 2002-11-05 2004-07-22 L'oreal Amines, uses thereof
CN101838205A (en) * 2009-03-16 2010-09-22 重庆北碚现代应用药物研究所 New method for preparing alverine citrate

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
枸椽酸阿尔维林的合成;杨丹等;《中国医药工业杂志》;20120310;第43卷(第3期);第164-166页 *

Also Published As

Publication number Publication date
CN103508898A (en) 2014-01-15

Similar Documents

Publication Publication Date Title
CN103508898B (en) A kind of preparation method of new alverine citrate
CN103601686A (en) Method for synthesizing fluorine-containing pyrimidine compounds by virtue of one-pot method
CN106800536A (en) A kind of preparation method of the miscellaneous Shandong amine of grace
CN102351778A (en) Preparation method of arbidol hydrochloride
CN106496038A (en) A kind of preparation method of 3 methyl, 2 nitrobenzoic acid of high selectivity
CN102079737A (en) Method for preparing apigenin
CN109485638A (en) A kind of uncommon preparation method for Buddhist nun's intermediate difficult to understand
CN110156645A (en) A kind of preparation method of florfenicol midbody
CN101654419A (en) Preparation method of fluvoxamine maleate
CN105693802A (en) Preparation method of 16 beta-methyl steroid
CN102491953A (en) Method for synthesizing florfenicol midbody RT0131
CN104447336B (en) A kind of three dish ene derivatives and preparation method thereof
CN104478974B (en) A kind of 20, the synthetic method of 23-dipiperidino-5-O-mycamino syl-tylono lide
CN104387284B (en) Synthesis methods of D9-clenbuterol hydrochloride labeled by deuterium and synthesis intermediate thereof
CN104326954B (en) A kind of synthetic method of Fudosteine
BR112013018345B1 (en) CATALYTIC CARBON-CARBON DOUBLE CONNECTION HYDROGENATION
CN103435477B (en) A kind of method of synthesizing paraethoxybenxoic acid
CN104193664B (en) A kind of synthetic method of imrecoxib
CN107188888A (en) A kind of methanesulfonic acid for preparing steps the auspicious method for Buddhist nun
CN104447509B (en) A kind of preparation technology of tirofiban hydrochloride
CN102643264A (en) Synthesizing method of trioxymethylene
CN109251138A (en) A kind of preparation method of all natural carbon source raspberry ketone
CN104672155B (en) A kind of synthetic method for improving quinocetone
CN107011288B (en) A kind of preparation method of aripiprazole intermediate 1- (2,3- dichlorophenyl) piperazine hydrochloride
CN106831549B (en) A kind of method of asymmetric synthesis of Claritin carbinoxamine

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
DD01 Delivery of document by public notice

Addressee: Zhao Kai

Document name: Notification of qualified procedures

DD01 Delivery of document by public notice